evans blue has been researched along with fluoxetine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Davidson, AE; Dowling, JJ; Horstick, E; Hur, J; Jackson, SW; Li, X; Waugh, TA | 1 |
3 other study(ies) available for evans blue and fluoxetine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.
Topics: Animals; Base Sequence; Birefringence; Calcium; Disease Models, Animal; Drug Evaluation, Preclinical; Dystrophin; Embryo, Nonmammalian; Evans Blue; Fluoxetine; Gene Expression Profiling; Gene Knockdown Techniques; Homeostasis; Molecular Sequence Data; Morpholinos; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Oligonucleotide Array Sequence Analysis; Phenotype; Serotonin Plasma Membrane Transport Proteins; Stress, Mechanical; Survival Analysis; Zebrafish | 2014 |